Home/Filings/4/0001628280-24-011485
4//SEC Filing

Koenig Sheldon L. 4

Accession 0001628280-24-011485

CIK 0001434868other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 4:30 PM ET

Size

6.9 KB

Accession

0001628280-24-011485

Insider Transaction Report

Form 4
Period: 2024-03-14
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2024-03-14+454,000766,816 total
  • Award

    Stock Option (right to buy)

    2024-03-14+642,000642,000 total
    Exercise: $2.05Exp: 2034-03-14Common Stock (642,000 underlying)
Footnotes (1)
  • [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2024.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001766524

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:30 PM ET
Size
6.9 KB